Author

L. Hagen

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cell Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 1 Organism:human· 1 Approach:machine learning (classical)· 1 Assay:whole-exome sequencing· 1

Frequent Co-Authors

A. Ianevski· 1 shared B. Aguilar· 1 shared B. Loera· 1 shared B. Tercan· 1 shared C. H. Pettersen· 1 shared D. E. Kainov· 1 shared E. Zusinaite· 1 shared G. Qin· 1 shared

Activity by Year

2020-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Ianevski

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia

G. Qin, J. Dai, S. Chien, T. J. Martins, B. Loera, Q. Nguyen, M. L. Oakes, B. Tercan, B. Aguilar, L. Hagen, J. McCune, R. Gelinas, R. J. Monnat, I. Shmulevich, P. S. Becker

The paper identifies mutation patterns linked to drug sensitivity in AML using integrated computational and experimental analysis.

bioRxiv · May 24, 2023Cell Biology

Potential antiviral options against SARS-CoV-2 infection

A. Ianevski, R. Yao, M. H. Fenstad, S. Biza, E. Zusinaite, H. Lysvand, K. Loeseth, V. M. Lamndsem, J. F. Malmring, V. Oksenych, S. E. Erlandsen, P. A. Aas, L. Hagen, C. H. Pettersen, J. E. Afset, , D. E. Kainov

The paper identifies potent convalescent sera and broad-spectrum antivirals effective against SARS-CoV-2 using a neutralization assay and cell culture screening.

bioRxiv · May 12, 2020Microbiology